Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

381
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
381
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

1.8K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.8K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

116
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
116
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

114
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
114
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

230
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
230

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Interpretable Deep Learning Framework Leveraging RNA Foundation Model and Capsule Networks for Accurate Prediction of RNA 2'-O-Methylation Sites.

Journal of chemical information and modeling·2026
Same author

A sequence knowledge-guided deep learning method for single-cell multi-omics translation.

Genome biology·2026
Same author

Enhancing anticancer peptide discovery: A fusion-centric framework with conditional diffusion for prediction and generation.

PLoS computational biology·2026
Same author

MultiPert: An adversarial alignment and dual attention framework for single-cell multi-omics perturbation prediction.

PLoS computational biology·2026
Same author

scGACL: a generative adversarial network with multi-scale contrastive learning for accurate single-cell RNA sequencing imputation.

Briefings in bioinformatics·2026
Same author

Synergistic adsorption-photocatalysis of In₂S₃/Bi₂₄Fe₂O₃₉ based on oxygen vacancy for efficient tetracycline removal.

Nanotechnology·2025

Related Experiment Video

Updated: Dec 17, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K

A Novel Triple Matrix Factorization Method for Detecting Drug-Side Effect Association Based on Kernel Target

Xiaoyi Guo1, Wei Zhou1, Yan Yu1

  • 1The Hemodialysis Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, 214000 Wuxi, China.

Biomed Research International
|June 30, 2020
PubMed
Summary
This summary is machine-generated.

Predicting drug side effects is crucial for patient safety. A new Triple Matrix Factorization (TMF) model accurately identifies potential drug-associated side effects using computational methods, improving upon existing techniques.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.4K

Related Experiment Videos

Last Updated: Dec 17, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.4K

Area of Science:

  • Pharmacology
  • Computational Biology
  • Bioinformatics

Background:

  • Drug side effects pose significant risks to patient health.
  • Traditional methods for identifying drug side effects are costly and time-consuming.
  • Computational approaches offer a faster and more accurate alternative for predicting drug-adverse event associations.

Purpose of the Study:

  • To propose a novel computational method for predicting potential drug-side effect associations.
  • To introduce the Triple Matrix Factorization (TMF) model for enhanced prediction accuracy.

Main Methods:

  • Developed a Triple Matrix Factorization (TMF) model based on Low Rank Approximation (LRA).
  • Integrated multivariate information using Kernel Target Alignment-based Multiple Kernel Learning (KTA-MKL).
  • Utilized biprojection matrices and latent features of kernels within the TMF framework.

Main Results:

  • The TMF model demonstrated superior performance compared to existing methods.
  • Achieved high Area Under the Precision-Recall curve (AUPR) values of 0.677, 0.685, and 0.680 on three benchmark datasets.
  • The LRA component effectively reduced data storage and computational complexity while preserving essential characteristics.

Conclusions:

  • The proposed TMF model is an effective computational tool for predicting drug side effects.
  • This method offers a promising approach for drug safety assessment and personalized medicine.
  • The integration of KTA-MKL enhances the model's ability to fuse complex biological data.